KRT18 and metabolic dysfunction-associated steatotic liver disease: These findings collectively suggest that CK18 may represent a biologically plausible indicator of hepatic–cardiac interaction, where NAFLD‐associated hepatocyte injury is associated with systemic inflammation and increased cardiovascular susceptibility.